Cathie Wood Reallocates ARK Funds: Exits Roku, Boosts Biotech and Tech Positions
Cathie Wood's ARK Invest executed significant portfolio adjustments on August 20, liquidating $7.12 million worth of Roku shares through its ARK Innovation ETF while simultaneously increasing exposure to biotech firms like Intellia Therapeutics and CRISPR Therapeutics. The moves underscore Wood's continued conviction in gene-editing technologies as a transformative force in healthcare.
ARK further demonstrated its tactical trading approach by purchasing $1.91 million in PagerDuty shares, capitalizing on the cloud platform's recent price weakness. This follows two previous acquisitions totaling $5.5 million earlier in the week, signaling a calculated accumulation strategy in the tech sector.